- Home
- KZIA vs KAVL Comparison
KZIA vs KAVL Comparison
Compare KZIA & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- KAVL
- Stock Information
- Founded
- KZIA 1994
- KAVL 1998
- Country
- KZIA Australia
- KAVL United States
- Employees
- KZIA N/A
- KAVL N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- KAVL Medicinal Chemicals and Botanical Products
- Sector
- KZIA Health Care
- KAVL Health Care
- Exchange
- KZIA Nasdaq
- KAVL Nasdaq
- Market Cap
- KZIA 7.8M
- KAVL 8.9M
- IPO Year
- KZIA 1999
- KAVL N/A
- Fundamental
- Price
- KZIA $1.42
- KAVL $1.13
- Analyst Decision
- KZIA Strong Buy
- KAVL
- Analyst Count
- KZIA 1
- KAVL 0
- Target Price
- KZIA $20.00
- KAVL N/A
- AVG Volume (30 Days)
- KZIA 116.4K
- KAVL 1.1M
- Earning Date
- KZIA 11-15-2024
- KAVL 02-13-2025
- Dividend Yield
- KZIA N/A
- KAVL N/A
- EPS Growth
- KZIA N/A
- KAVL N/A
- EPS
- KZIA N/A
- KAVL N/A
- Revenue
- KZIA $1,655,324.00
- KAVL $10,108,906.00
- Revenue This Year
- KZIA $806.89
- KAVL $652.90
- Revenue Next Year
- KZIA N/A
- KAVL N/A
- P/E Ratio
- KZIA N/A
- KAVL N/A
- Revenue Growth
- KZIA 248000.00
- KAVL N/A
- 52 Week Low
- KZIA $1.39
- KAVL $0.58
- 52 Week High
- KZIA $15.80
- KAVL $9.69
- Technical
- Relative Strength Index (RSI)
- KZIA 20.74
- KAVL 59.46
- Support Level
- KZIA $1.42
- KAVL $0.95
- Resistance Level
- KZIA $1.89
- KAVL $1.28
- Average True Range (ATR)
- KZIA 0.24
- KAVL 0.21
- MACD
- KZIA 0.02
- KAVL 0.02
- Stochastic Oscillator
- KZIA 1.40
- KAVL 45.24
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.